New CEO appointed, existing CEO steps aside to focus on MD role

Ceo ResignedCeo Appointed ExternalManagement Changes View source PDF

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.6%1-day move

₹504.00

prior close

₹505.95

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.7+1.4+0.7+0.4+0.6+0.9+4.5+4.2+5.2+2.2-9.4———

Up moveDown movePending

AI summary

Bliss GVS Pharma Board has approved Mr. Rahul Adakmol (ex-Bharat Serums, Dr. Reddy's, Reliance) as CEO effective July 15, 2026. Current CEO Mr. Narsimha Kamath steps aside from CEO role on July 14, 2026 but continues as Managing Director. Mr. Santosh Parab joins as Non-Executive Non-Independent Director.

Likely market impact

Smooth leadership transition. Incoming CEO brings 22 years of pharma CXO experience. Continuity assured as outgoing CEO stays as Managing Director.